<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01943669</url>
  </required_header>
  <id_info>
    <org_study_id>13/EE/0048 (UK NRES)</org_study_id>
    <nct_id>NCT01943669</nct_id>
  </id_info>
  <brief_title>Exoskeletons for Spinal Cord Injury: A Feasibility Study</brief_title>
  <official_title>An Open, Longitudinal, Prospective, Non-randomized, Self-Controlled Feasibility Study to Investigate the Effect of the ReWalk™ Device on Mobility Outcomes in Patients With Chronic Spinal Cord Injury.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Buckinghamshire Healthcare NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Buckinghamshire Healthcare NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, 10 volunteer participants with chronic spinal cord injury will undergo a&#xD;
      10-week training schedule for ambulation with the ReWalk™ device. The ReWalk™ consists of a&#xD;
      lightweight brace-support suit containing motors at the hip and knee joints, rechargeable&#xD;
      batteries and a computerized control system carried in a backpack. ReWalk™ users control&#xD;
      their ambulation through subtle changes in centre of gravity and upper-body movements.&#xD;
      Before, during and after training sessions the volunteers will perform standardised&#xD;
      assessments and complete questionnaires to assess the functional and psychological effects of&#xD;
      the exoskeleton. Functional outcomes primarily focus on ambulation outcomes and psychological&#xD;
      outcomes primarily focus on predisposition and perceptions of disability. The outcomes of&#xD;
      this pilot study will assist the investigators in the preparations of randomised controlled&#xD;
      trail for assessing the efficacy of the ReWalk™ device in a neurorehabilitation setting.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, 10 volunteer participants with chronic spinal cord injury will undergo a&#xD;
      10-week training schedule for ambulation with the ReWalk™ device. The ReWalk™ consists of a&#xD;
      lightweight brace-support suit containing motors at the hip and knee joints, rechargeable&#xD;
      batteries and a computerized control system carried in a backpack. ReWalk™ users control&#xD;
      their ambulation through subtle changes in centre of gravity and upper-body movements.&#xD;
      Before, during and after training sessions the volunteers will perform standardised&#xD;
      assessments and complete questionnaires to assess the functional and psychological effects of&#xD;
      the exoskeleton. Twenty one-hour training sessions are scheduled for each participant over a&#xD;
      10-week period. Functional outcomes primarily focus on ambulation outcomes and psychological&#xD;
      outcomes primarily focus on predisposition and perceptions of disability. The outcomes of&#xD;
      this pilot study will assist the investigators in the preparations of randomised controlled&#xD;
      trail for assessing the efficacy of the ReWalk™ device in a neurorehabilitation setting.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>10-meter walking test (10MWT)</measure>
    <time_frame>10 weeks</time_frame>
    <description>Change in score between 0 and 10 weeks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>6-minutes walk test (6MWT)</measure>
    <time_frame>10 weeks</time_frame>
    <description>Change in score between 0 and 10 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Timed Up and Go (TUG) test</measure>
    <time_frame>10 weeks</time_frame>
    <description>Change in score between 0 and 10 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assistive Technology Device Predisposition Assessment© (ATDPA) Questionnaire</measure>
    <time_frame>10 weeks</time_frame>
    <description>Change in score between 0 and 10 weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appraisals of Disability: Primary and Secondary Scale (ADAPSS) Questionnaire</measure>
    <time_frame>10 weeks</time_frame>
    <description>Change in score between 0 and 10 weeks.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Stair management</measure>
    <time_frame>10 weeks</time_frame>
    <description>Exact timing pending learning curve, change in score in weeks up to 10 weeks.</description>
  </other_outcome>
  <other_outcome>
    <measure>Obstacle course</measure>
    <time_frame>10 weeks</time_frame>
    <description>Exact timing pending learning curve, change in score in weeks up to 10 weeks.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Spinal Cord Injury</condition>
  <arm_group>
    <arm_group_label>ReWalk™ device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Self-controlled group; single cohort.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ReWalk™ device</intervention_name>
    <description>Twenty one-hour ReWalk™ training sessions are scheduled for each participant over a 10-week period.</description>
    <arm_group_label>ReWalk™ device</arm_group_label>
    <other_name>Exoskeleton</other_name>
    <other_name>Bionic suit</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American Spinal Injury Association (ASIA) Impairment Scale (AIS) grade A, B &amp; C (Lower&#xD;
             Extremity Motor Score &lt;20)&#xD;
&#xD;
          -  Motor level of injury from Cervical level 7 to Lumbar level 1, according to ASIA&#xD;
             guidelines&#xD;
&#xD;
          -  Male and non-pregnant, non-lactating female&#xD;
&#xD;
          -  Age 18-55 years old&#xD;
&#xD;
          -  At least 12 months after injury&#xD;
&#xD;
          -  Able to stand or maintain upright position with or without using a standing device&#xD;
             (e.g., 'Easy stand')&#xD;
&#xD;
          -  Able to sit with hips and knees ≥90° flexion&#xD;
&#xD;
          -  Height of 160 to 190 cm&#xD;
&#xD;
          -  Weight of &lt;100 kg&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of severe neurological injuries other than spinal cord injury (eg. Multiple&#xD;
             Sclerosis, Cerebral Palsy, Amyotrophic Lateral Sclerosis, Traumatic Brain Injury,&#xD;
             Stroke)&#xD;
&#xD;
          -  Concurrent medical diseases (eg. infections, circulatory, heart or lung, pressure&#xD;
             sores) interfering with the study&#xD;
&#xD;
          -  Unstable spine or unhealed limbs or pelvic fractures&#xD;
&#xD;
          -  Limited range of motion (&lt;90°) hip and knee joints, including severe contractures&#xD;
&#xD;
          -  Severe spasticity (Ashworth grade 4; ie. Affected part(s) rigid in flexion or&#xD;
             extension) or uncontrolled clonus&#xD;
&#xD;
          -  Diagnosis of severe osteoporosis/penia as proven with pQCT or DXA.&#xD;
&#xD;
          -  Psychiatric or cognitive conditions that may interfere with the trial&#xD;
&#xD;
          -  Previous use of any exoskeletal robotic device&#xD;
&#xD;
          -  Patients incapable of providing informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joost J. van Middendorp, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stoke Mandeville Spinal Foundation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joost J. van Middendorp, MD, PhD</last_name>
    <phone>+44 1296 316783</phone>
    <email>Joost.vanMiddendorp@buckshealthcare.nhs.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Spinal Injuries Centre, Stoke Mandeville Hospital</name>
      <address>
        <city>Aylesbury</city>
        <state>Buckinghamshire</state>
        <zip>HP21 8AL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joost J. van Middendorp, MD, PhD</last_name>
      <phone>+44 1296316783</phone>
      <email>Joost.vanMiddendorp@buckshealthcare.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Joost J. van Middendorp, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>I Benson, BSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>K Hart, BSc, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>D Tussler, BSc, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.smsf.org.uk/research%20introduction.htm</url>
    <description>Website directing to project description and updates</description>
  </link>
  <verification_date>September 2013</verification_date>
  <study_first_submitted>July 22, 2013</study_first_submitted>
  <study_first_submitted_qc>September 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2013</study_first_posted>
  <last_update_submitted>September 16, 2013</last_update_submitted>
  <last_update_submitted_qc>September 16, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Spinal Cord Injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

